168 related articles for article (PubMed ID: 26220525)
21. Deubiquitinase Mysm1 regulates neural stem cell proliferation and differentiation by controlling Id4 expression.
Xu Z; Qin Q; Wang Y; Zhang H; Liu S; Li X; Chen Y; Wang Y; Ruan H; He W; Zhang T; Yan X; Wang C; Xu D; Jiang X
Cell Death Dis; 2024 Feb; 15(2):129. PubMed ID: 38342917
[TBL] [Abstract][Full Text] [Related]
22. Epigenetic control of natural killer cell maturation by histone H2A deubiquitinase, MYSM1.
Nandakumar V; Chou Y; Zang L; Huang XF; Chen SY
Proc Natl Acad Sci U S A; 2013 Oct; 110(41):E3927-36. PubMed ID: 24062447
[TBL] [Abstract][Full Text] [Related]
23. Deubiquitinase MYSM1 Is Essential for Normal Fetal Liver Hematopoiesis and for the Maintenance of Hematopoietic Stem Cells in Adult Bone Marrow.
Förster M; Belle JI; Petrov JC; Ryder EJ; Clare S; Nijnik A
Stem Cells Dev; 2015 Aug; 24(16):1865-77. PubMed ID: 26125289
[TBL] [Abstract][Full Text] [Related]
24. The basic helix-loop-helix transcription factor E2-2 is involved in T lymphocyte development.
Bergqvist I; Eriksson M; Saarikettu J; Eriksson B; Corneliussen B; Grundström T; Holmberg D
Eur J Immunol; 2000 Oct; 30(10):2857-63. PubMed ID: 11069067
[TBL] [Abstract][Full Text] [Related]
25. [Deubiquitinase MYSM1 Regulates Differentiation of Human B Cells to Plasma Cells].
Zhong KL; Huang XH; Wang YH; Wang B; Wang WX; Wang YH; Zhang WJ; Jiang XX
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2019 Oct; 27(5):1627-1632. PubMed ID: 31607324
[TBL] [Abstract][Full Text] [Related]
26. Loss of p53 compensates osteopenia in murine Mysm1 deficiency.
Haffner-Luntzer M; Kovtun A; Fischer V; Prystaz K; Hainzl A; Kroeger CM; Krikki I; Brinker TJ; Ignatius A; Gatzka M
FASEB J; 2018 Apr; 32(4):1957-1968. PubMed ID: 29203593
[TBL] [Abstract][Full Text] [Related]
27. MYSM1-dependent checkpoints in B cell lineage differentiation and B cell-mediated immune response.
Förster M; Farrington K; Petrov JC; Belle JI; Mindt BC; Witalis M; Duerr CU; Fritz JH; Nijnik A
J Leukoc Biol; 2017 Mar; 101(3):643-654. PubMed ID: 27895164
[TBL] [Abstract][Full Text] [Related]
28. MYSM1 Is Essential for Maintaining Hematopoietic Stem Cell (HSC) Quiescence and Survival.
Huo Y; Li BY; Lin ZF; Wang W; Jiang XX; Chen X; Xi WJ; Yang AG; Chen SY; Wang T
Med Sci Monit; 2018 Apr; 24():2541-2549. PubMed ID: 29694335
[TBL] [Abstract][Full Text] [Related]
29. Repression of p53-target gene Bbc3/PUMA by MYSM1 is essential for the survival of hematopoietic multipotent progenitors and contributes to stem cell maintenance.
Belle JI; Petrov JC; Langlais D; Robert F; Cencic R; Shen S; Pelletier J; Gros P; Nijnik A
Cell Death Differ; 2016 May; 23(5):759-75. PubMed ID: 26768662
[TBL] [Abstract][Full Text] [Related]
30. Neutrophilic Panniculitis in a child with MYSM1 deficiency.
Nanda A; Al-Abboh H; Zahra A; Al-Sabah H; Gupta A; Adekile AD
Pediatr Dermatol; 2019 Mar; 36(2):258-259. PubMed ID: 30746751
[TBL] [Abstract][Full Text] [Related]
31. A role for the histone H2A deubiquitinase MYSM1 in maintenance of CD8
Förster M; Boora RK; Petrov JC; Fodil N; Albanese I; Kim J; Gros P; Nijnik A
Immunology; 2017 May; 151(1):110-121. PubMed ID: 28066899
[TBL] [Abstract][Full Text] [Related]
32. [A novel compound heterozygous mutation in MYSM1 gene in a 1-month-old girl: a bone marrow failure syndrome 4 family survey and literature review].
Huang J; Zhan XY; Zhao AL; Wu B; Yang Y; Tan P; Wan LJ; Lu YH
Zhonghua Xue Ye Xue Za Zhi; 2021 Feb; 42(2):129-134. PubMed ID: 33858043
[No Abstract] [Full Text] [Related]
33. MYSM1 induces apoptosis and sensitizes TNBC cells to cisplatin via RSK3-phospho-BAD pathway.
Guan X; Meng X; Zhu K; Kai J; Liu Y; Ma Q; Tong Y; Zheng H; Xie S; Ma X; Wang Y; Lu R; Guo L
Cell Death Discov; 2022 Feb; 8(1):84. PubMed ID: 35217648
[TBL] [Abstract][Full Text] [Related]
34. MYSM1 Suppresses Cellular Senescence and the Aging Process to Prolong Lifespan.
Tian M; Huang Y; Song Y; Li W; Zhao P; Liu W; Wu K; Wu J
Adv Sci (Weinh); 2020 Nov; 7(22):2001950. PubMed ID: 33240758
[TBL] [Abstract][Full Text] [Related]
35. c-Myb and p300 regulate hematopoietic stem cell proliferation and differentiation.
Sandberg ML; Sutton SE; Pletcher MT; Wiltshire T; Tarantino LM; Hogenesch JB; Cooke MP
Dev Cell; 2005 Feb; 8(2):153-66. PubMed ID: 15691758
[TBL] [Abstract][Full Text] [Related]
36. Mysm1 epigenetically regulates the immunomodulatory function of adipose-derived stem cells in part by targeting miR-150.
Wang YH; Huang XH; Yang YM; He Y; Dong XH; Yang HX; Zhang L; Wang Y; Zhou J; Wang C; Jiang XX
J Cell Mol Med; 2019 May; 23(5):3737-3746. PubMed ID: 30895711
[TBL] [Abstract][Full Text] [Related]
37. Human hematopoietic stem cell vulnerability to ferroptosis.
Zhao J; Jia Y; Mahmut D; Deik AA; Jeanfavre S; Clish CB; Sankaran VG
Cell; 2023 Feb; 186(4):732-747.e16. PubMed ID: 36803603
[TBL] [Abstract][Full Text] [Related]
38. MYSM1 is mutated in a family with transient transfusion-dependent anemia, mild thrombocytopenia, and low NK- and B-cell counts.
Alsultan A; Shamseldin HE; Osman ME; Aljabri M; Alkuraya FS
Blood; 2013 Nov; 122(23):3844-5. PubMed ID: 24288411
[No Abstract] [Full Text] [Related]
39. c-Myb and Ets proteins synergize to overcome transcriptional repression by ZEB.
Postigo AA; Sheppard AM; Mucenski ML; Dean DC
EMBO J; 1997 Jul; 16(13):3924-34. PubMed ID: 9233802
[TBL] [Abstract][Full Text] [Related]
40. Whole-exome sequencing identifies Coronin-1A deficiency in 3 siblings with immunodeficiency and EBV-associated B-cell lymphoproliferation.
Moshous D; Martin E; Carpentier W; Lim A; Callebaut I; Canioni D; Hauck F; Majewski J; Schwartzentruber J; Nitschke P; Sirvent N; Frange P; Picard C; Blanche S; Revy P; Fischer A; Latour S; Jabado N; de Villartay JP
J Allergy Clin Immunol; 2013 Jun; 131(6):1594-603. PubMed ID: 23522482
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
